Diabetes

Article	Citations
Comment on Carrasco et al. Spatial Environment Affects HNF4A Mutation-Specific Proteome Signatures and Cellular Morphology in hiPSC-Derived β-Like Cells. Diabetes 2022;71:862–869	146
Unveiling Novel Markers and Modeling Clinical Prediction of Treatment Effects Are Equally Important for Implementing Precision Therapeutics	119
Polygenic Risk for Type 2 Diabetes in African Americans	69
An Expanded Genome-Wide Association Study of Fructosamine Levels Identifies RCN3 as a Replicating Locus and Implicates FCGRT as the Effector Transcript	69
Comparison of β-Cell Function and Insulin Sensitivity Between Normal-Weight and Obese Chinese With Young-Onset Type 2 Diabetes	68
Expression of Concern. Shuangxi Wang, Jian Xu, Ping Song, Benoit Viollet, and Ming-Hui Zou. In Vivo Activation of AMP-Activated Protein Kinase Attenuates Diabetes-Enhanced Degradation of GTP Cyclohydr	65
Building the Glucagon-Like Peptide-1 Receptor Brick by Brick: Revisiting a 1993 Diabetes Classic by Thorens et al.	63
A Randomized Controlled, Double-Masked, Crossover Study of a GPR119 Agonist on Glucagon Counterregulation During Hypoglycemia in Type 1 Diabetes	62
Surplus Ceramides: An Added Twist in the Tale of TREM2 and Insulin Resistance	62
Deficiency of the Hemoglobin-Haptoglobin Receptor, CD163, Worsens Insulin Sensitivity in Obese Male Mice	60
Perilipin 1 Antibodies in Patients With Acquired Generalized Lipodystrophy	59
Foxj3 Regulates Thermogenesis of Brown and Beige Fat Via Induction of PGC-1α	58
Of Mice and Men: Toward a Better Model of Diabetic Cardiomyopathy With Application in Female Animals	58
Plasma Neuronal Growth Regulator 1 May Link Physical Activity to Reduced Risk of Type 2 Diabetes: A Proteome-Wide Study of ARIC Participants	58
Loss of Glomerular Permselectivity in Type 2 Diabetes Associates With Progression to Kidney Failure	55
Protein Markers of Diabetes Discovered in an African American Cohort	54
Adenylosuccinate Mediates Imeglimin-Induced Proliferative and Antiapoptotic Effects in β-Cells	54
Intermittent Leucine Deprivation Produces Long-lasting Improvement in Insulin Sensitivity by Increasing Hepatic Gcn2 Expression	51
A 3-Week Ketogenic Diet Increases Skeletal Muscle Insulin Sensitivity in Individuals With Obesity: A Randomized Controlled Crossover Trial	51
Electrophysiological Characterization of Inducible Pluripotent Stem Cell–Derived Human β-Like Cells and an SLC30A8 Disease Model	50
Protective Renalase Deficiency in β-Cells Shapes Immune Metabolism and Function in Autoimmune Diabetes	50
lncRNA-H19 in Fibroblasts Promotes Wound Healing in Diabetes	49
Upregulation of Acid-Sensing Ion Channel 1a in the Anterior Cingulate Cortex by TNF-α/NF-κB Pathway Contributes to Diabetes-Related Pain	48
Higher HbA1c Is Associated With Greater 2-Year Progression of White Matter Hyperintensities	48
High-Intensity Interval Training, Caloric Restriction, or Their Combination Have Beneficial Effects on Metabolically Acquired Peripheral Neuropathy	44

Therapeutic Targets for Diabetic Kidney Disease: Proteome-Wide Mendelian Randomization and Colocalization Analyses	44
611-P: Do Social Needs Impact Quality of Life among Adult Medicaid Beneficiaries with Type 2 Diabetes?	43
140-OR: Adoption of State-Level Complete Streets Legislations and U.S. Prevalence of Obesity	43
44-LB: Evaluating the Effectiveness of a Novel Form of Online Cognitive Behavioural Therapy for Patients with Type 2 Diabetes and Comorbid Anxiety or Depression	42
502-P: Increasing Provider Referrals to Diabetes Self-Management Education and Support Services: Recommendations from Virtual Focus Groups with Providers in New York State	40
296-OR: Glucagon and Insulin Cross Talk Regulates Hepatic Glycogen Metabolism	39
1-PUB: Impaired Kidney Function in Diabetic Patients—A Warning	39
671-P: Development of Novel Infrastructure for Diabetes Distress Screening in the Electronic Health Record	38
507-P: Human Liver-Specific Regulation of Lipogenesis by Long Noncoding RNA hLMR1	38
1946-LB: Patterns of Insulin Discontinuation in Youth with New-Onset Type 2 Diabetes	36
1736-P: Exploring Intrinsic Features of Human Pancreatic a- and ß-Cell Physiology Using Pseudoislets	36
72-OR: A Novel Multiancestry Polygenic Score Improves T1D Risk Prediction in Non-European Populations	36
1126-P: Smart Insulin Pens—A Randomized, Crossover Pilot Trial Assessing Glycemic Control and Diabetes-Related Burdens in Adolescents and Emerging Adults with Diabetes	35
238-OR: Changes In Renal Function after Islet Transplantation in a Single-Centre Cohort in Canada over 20 Years	35
785-P: Preclinical Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) Assessments of Sustained-Released Formulation of Once-Monthly Injectable Semaglutide (PT403)	35
1022-P: Youth from High-Poverty Neighborhoods Demonstrate Higher HbA1c within Year after Diagnosis of T1D	34
447-P: C/EBPß-Lin28a Positive Feedback Loop Mediated by C/EBPß Hypomethylation Promotes the Proliferation and Migration of Vascular Smooth Muscle Cells in Restenosis	33
1895-LB: Randomized Controlled Trial in a Real-World Setting Shows a Light Touch “Food Is Medicine” Program Improves Health Behaviors and Self-Reported Health Status in People with Diabetes	32
2059-LB: NA-931, a Novel Triple IGF-1/GLP-1/GIP Incretin Receptor Agonist Reduces Body Weight and Improves Metabolic Profile in DIO Mice	32
283-OR: Adipose Stromal Cells Increase Insulin Sensitivity and Decrease Liver Gluconeogenesis in a Type 1 DM Mouse Model	31
167-LB: Knowledge Retention and Glycemic Control in Participants of Kids in Control of Food (KICk OFF) Program—Virtual vs. On-Site	31
2176-LB: Circadian Clock Regulation of HIF1a-Dependent Skeletal Muscle Metabolism during Diet-Induced Obesity	30
1066-P: Sleep Habits and Their Impact on CGM Parameters in Patients with Type 1 Diabetes	30
2111-LB: Discrepancies between Creatinine-Cystatin C-Based and Creatinine-Based eGFR and Their Association with Vascular Complications in Adults With Diabetes—The China Diachronic Study	30
594-P: Exercise Timing Has Limited Effect on Glycemic Profile in a Cluster of Well-Controlled Youth with Type 1 Diabetes	30
32-PUB: Glycemic Variability after Initiation of SGLT2 Inhibitors in CKD	30
10-LB: Activation of Sigma-1 Receptor as a Novel Therapeutic Target in Diabetic Kidney Disease	29
1301-P: The Effect of Insulin on α-Aminoadipic Acid Metabolism in Polycystic Ovary Syndrome (PCOS) Patients with Insulin Resistance	29
258-OR: Sustainability of HbA1c Control of Tirzepatide vs. Insulin Glargine in People with Type 2 Diabetes and Increased Cardiovascular Risk (SURPASS-4)	29
1148-P: Risk Factor Control and Risk of Hospitalization for Heart Failure in Diabetic Patients	29
770-P: Efficacy and Safety of Tirzepatide in Participants Who Achieved Fasting Serum Glucose Targets at 52 Weeks in SURPASS-3 and SURPASS-4	29
1844-LB: Community Engaged Research—Lessons Learned from a Pediatric Type 1 Diabetes Study	29
46-OR: Amelioration of Insulin Resistance after Delivery Lowers the Risk of Postpartum Type 2 Diabetes in Women with Gestational Diabetes Mellitus	29
612-P: The Effectiveness of Lifestyle, Metformin, or Dietary Supplements for the Prevention of Gestational Diabetes Mellitus (GDM) by Participant Characteristics—A Systematic Review and Meta-analysis	28
933-P: Effects of Dapagliflozin and Metformin on Vascular Function in Newly Diagnosed Type 2 Diabetes—A Randomized Controlled Trial (DMVascular Study)	28
1422-P: Understanding COVID-19 Impacts among Underserved Adults with Diabetes Using the Social-Ecological Model	27
385-P: MDSC-Mediated Neutrophil Extracellular Traps–Based Targeting of Diabetic Vasculopathy—Dapagliflozin for Vascular Remodeling in Diabetic Nephropathy	27
1629-P: Association between Dyslipidemia and Myosteatosis Evaluated by Abdominal Computed Tomography	26
150-LB: Diabetes and School Health (DASH) Program—An Innovative School-Based Health Model to Optimize Care for Youth with Type 1 Diabetes	26
999-P: Cost-Effectiveness of MiniMed 780G Therapy Compared with Multiple Daily Injections (MDI) with Intermittently Scanned Continuous Glucose Monitoring (isCGM) in People with Type 1 Diabetes (T1D)—A	26
1127-P: 4T Study—Early CGM Initiation and Tighter Glucose Targets Improves A1C in Youth with T1D	26
932-P: MiniMed 780G System Use in a Real-World United States (U.S.) Population Aged 65 Years and Older with Diabetes	26
1588-P: Translatable Modeling of Glucagon Actions in Human iPSC-Derived Hepatocytes Uniquely Predicts Differential Clinical Responses to Glucagon Analog Agonist Molecules	26
571-P: Theory-Based Design of a Nutrition-Focused Approach at CGM Initiation for People with T2D	25
849-P: Antidiabetic Effects of TLC-3595, a Selective ACC2 Inhibitor, in ZDF Rats	25
1137-P: Continuous Glucose Monitoring (CGM) Use and Its Impact on Glycemic Control and Acute Complications among Older-Onset Type 1 Diabetes Patients within the Veterans Health Administration (VHA)	25
1452-P: Financial Toxicity and Cost-Related Nonadherence (CRN) in Adults with Type 1 Diabetes (T1D)—Prevalence and Associations with Social Determinants of Health	25
2188-LB: Associations between Alzheimer's Disease (AD) and Obesity—Clinical Trials of NA-813 for AD and NA-931 for Obesity	25
632-P: Beta-Cell Function Is a Stronger Predictor Than Insulin Resistance for Development of Type 2 Diabetes in Obese Indian Population—A Matched-Pair Cohort Analysis	25
118-OR: Fat Distribution Patterns Predict Type 2 Diabetes Risk and Provide Insights into Prediabetic Metabolism	25

1706-P: Software-Aided Self Selection of Weight Loss Diet Plan for Facilitating Diabetes Management in Primary Care	24
727-P: A Phase 3 Evaluation of CAMP-Biased GLP-1 Analog Ecnoglutide vs. Dulaglutide in Adults with Type 2 Diabetes	24
1571-P: Plasma FGF5 Concentration Correlates Better with Hepatic Steatosis, Blood Glucose, and Specific Plasma Free Fatty Acids than with Other Tissue Fat Accumulation	24
1604-P: The Severity of Metabolic Dysfunction–Associated Steatohepatitis (MASH) Is Associated with Worse Hepatic Steatosis and Insulin Resistance	24
607-P: Associations of Gut Microbiome with Glycemic Control in a Carbohydrate-Restricted, High-Protein Diet for Type 2 Diabetes Mellitus	24
Lrtm1 - A Novel Sensor of Insulin Signaling and Regulator of Metabolism and Activity	24
1526-P: A Clinically Optimized Genetic Prediction Model for Differentiating Type 1 and Type 2 Diabetes	23
204-OR: An Early Immune Signature in Prediabetes Can Predict Progression to Type 2 Diabetes	23
79-OR: Targeted Erasure of DNA Methylation by TET3 with C/EBPδ Rewires Adipogenic Execution for Energy Metabolism	23
227-LB: Kynurenine Pathway Is Associated with Preservation of Beta-Cell Function in Autoimmune Diabetes	23
429-P: The Difference between Cystatin C- and Creatinine-Based Estimated Glomerular Filtration Rate in Relation to Carotid Plaque Score in Patients with Type 2 Diabetes	22
1760-P: Mining Animal Venoms as a Source of Insulinotropic Peptides for Potential Diabetes Therapy	22
1713-P: Deletion of SGK1 in Smooth Muscle Cells Induces Adipose Tissue Beiging and Differential Secretion of Vasokines	22
1762-P: Regional Body Fat Distribution Is Associated with Higher Risk for Sleep Deficiency and Sleep Disorders	22
1126-P: Does the Use of a Case Manager Matter in Diabetes Care?	22
1726-P: Comparison of Subcutaneous, Visceral, Liver, and Muscle Fat Depots in Relation to Diabetes Risk—A Prospective Cohort Study	22
1807-PUB: Monocarbonyl Curcumin Analogs C66 and B2BrBC Improve Redox Status in Streptozotocin-Induced Diabetic Rats	22
17-PUB: Glucagon-Like Peptide 1 Receptor Agonists' Heterogeneous Treatment Effects on Asthma Exacerbations—A Causal Machine-Learning Analysis	22
1223-P: Frequency and Predictors of Level 2 Time Above Range (TAR) in Older Adults with Type 2 Diabetes on Insulin Therapy—Data from the HYPOAGE Prospective Study	22
1908-LB: A Machine-Learning Framework to Quantify Postprandial Glucose Responses in Gestational Diabetes	22
1707-P: Real-World 12-Month Weight Loss Outcomes of Tirzepatide—The Mayo Clinic Experience	22
1801-LB: Discovering Novel Cathepsin L Inhibitors Using Artificial Intelligence for Diabetic Nephropathy	21
1635-P: Short-Term Production of Circulating Triglycerides Is Positively Associated with Triglyceride Concentration in Adolescents with and without MASLD	21
726-P: Medication Adherence among American Indians with Type 2 Diabetes—Assessing the Quality of Electronic Health Record Data within a Large Tribal Health Care System	21
1661-P: Exogenous Oxytocin Has No Effect on Ad Libitum Food Intake or Postprandial Plasma Glucose Concentrations in Individuals with Obesity	21
2060-LB: Benchmarking AI in Type 1 Diabetes Management—How Well Do Generative AI Platforms Follow ADA SOC?	21
1040-P: Feasibility and Performance of Continuous Glucose Monitoring (CGM) to Guide Computerized Insulin Infusion Therapy in Cardiovascular Intensive Care Unit (CV-ICU)	21
1397-P: A Cocoa Butter–Based Ketogenic Diet Fails to Improve Glucose Homeostasis and Promote Weight Loss in Obese Mice	21
94-OR: Pathogenic Action of GAD65 Autoantibodies on Islet Function in Type 1 Diabetes	20
983-P: Long-Term Improvement in CGM-Measured Glycemic Control in Adults with Type 2 Diabetes Not Treated with Insulin—Real-World Data	20
1849-LB: Social Determinants of Health and Early-Onset Type 2 Diabetes—A Qualitative Study	20
352-OR: Regulation of Melanocortin Receptor 4 (MC4R) Ciliary Trafficking	20
2054-LB: Mitigating Adipose Tissue Dysfunction and Insulin Resistance in Obesity via SVEP1 Peptide-Mediated Suppression of Adipose Tissue Macrophage-Induced Inflammation	20
661-P: Use of a Sequential Continuous Glucose Monitoring with or without Exercise Tracker on Glycaemic Control in Middle-Aged Patients with Diabetes Mellitus	20
1082-P: Online Clinician Education Results in Performance Changes in Clinical Practice Related to Obesity Management in Patients With and Without Type 2 Diabetes	20
1465-P: Identification of GCK Gene Variants and Clinical Characterization in Japanese Pediatric MODY2 Cases	20
1081-P: Trends in Treatment Goal Attainment of Cardiovascular Risk Factors in Chilean Adults with Diabetes Mellitus—Results from the National Health Survey 2016–2017	20
141-LB: Cost-Effectiveness of Real-Time Continuous Glucose Monitoring (rt-CGM) vs. Intermittent-Scanning Continuous Glucose Monitoring (is-CGM) from a U.S. Payer Perspective in Patients with Type 2 Di	19
71-OR: ADA Presidents' Select Abstract: HLA-Focused Meta-Genetic Risk Score (GRS) Performance in Populations of Diverse Ancestry with Type 1 Diabetes	19
1478-P: Polygenic Risk Score Predicts Incident Cardiovascular Disease in People with Diabetes at Borderline or Intermediate 10-Year ASCVD Risk	19
1682-P: Factors Associated with Postprandial Suppression of Endogenous Glucose Production in People without Diabetes	19
574-P: Meta-analysis Shows Mind- and Body-Based Interventions Improve Glycemic Control in Patients with Type 2 Diabetes	19
880-P: Effects of Energy Dosing on Safety and Efficacy in an Open-Label Study of Endoscopic Pulsed Electric Field Induced Electroporation in Type 2 Diabetes (REGENT-1 Trial)	19
1708-P: Development of a Needle-Free, Self-Applied Microarray Patch for GLP-1 Delivery	19
249-OR: Cystatin C Predicts Cardiovascular Events in Patients with Coronary Artery Disease Both among Patients with and among Those without Type 2 Diabetes	19
1740-P: Regulation of Endocrine Cell Alternative Splicing Revealed by Single-Cell RNA Sequencing in Type 2 Diabetes	18
921-P: Impact of Heart Rate and Step Count on Deep Learning Glucose Prediction Models during Physical Activity	18
68-OR: Influence of the Type 1 Diabetes Genetic Risk Score on Response to Immunotherapies for Type 1 Diabetes Prevention	18
1638-P: Oxidized Lipids Cause Ceramide Accumulation and Insulin Resistance in Skeletal Muscle	18
337-OR: Tirzepatide Improved Markers of Islet-Cell Function (Fasting Glucagon and HOMA2-B) and Insulin Sensitivity (Fasting Insulin and HOMA2-IR) Compared with Semaglutide in People with Type 2 Diabet	18
1451-P: Peri-Islet Fibrosis in Cystic Fibrosis Is Associated with Altered Alpha-Cell Phenotype	18
171-LB: Estimating the Immunological Risk for Type 1 Diabetes from a CGM-Based One Week Self-Administered Home Test	18
2037-LB: Considerations for Calculating and Reporting CGM Wear-Time in Research Settings	18
1034-P: No “Honeymoon” for Youth, in Particular Blacks, Diagnosed with Diabetes during the First Year of the COVID-Pandemic	18
261-OR: Validation of Mitraa, a GPT-Based Conversational Model for Enhancing Diabetes Self-Management and Education	18
697-P: Evaluation of Acceptance and Commitment Therapy on Glycemic Control in Type 2 Diabetes Patients	18
1078-P: Elderly Patient with DM2 during the COVID-Pandemia: Forgotten but Good Glycemic Control	18
468-P: Association between Sudomotor Function and Coronary Atherosclerosis in Patients with Type 2 Diabetes	18
1558-P: Immunological Role of Hybrid Insulin Peptide in Type 1 Diabetes in Asia	17
240-OR: Quantifying Glucose Utilization and Endogenous Glucose Production during Resistance Exercise in People with Type 1 Diabetes (T1D)	17
252-OR: Maternal Obesity and Diabetes during Pregnancy and Quantitative Checklist for Autism in Toddlers (QCHAT) Scores in Offspring	17
1641-P: Effect of Specific Weight-Reducing Interventions on Metabolic and Immunological Outcomes in Mice	17
280-OR: Insulin Sensitivity following an In-Home Sleep and Circadian Intervention for Habitually Short-Sleeping Adolescents	17
1591-P: Effects of Light Exposure during Sleep on Glycemic Control in Type 1 Diabetes	17
1586-P: Association between PCSK7 Levels and NAFLD Severity in KADEM Study	17
562-P: A Social Media Intervention Shows Promise to Improve Health Outcomes in Low-Income Immigrants with Type 2 Diabetes—Evidence from a Pilot RCT	17
718-P: A High FODMAP Diet Reduces Glycemic Excursion without Increasing Gastrointestinal Symptoms in Individuals with Prediabetes Treated with Metformin—A Randomized Crossover Controlled-Feeding Trial	17
727-P: A New HbA1c Test Based on a Cellular Stiffness Measurement of Red Blood Cells	17
478-P: Application of Plasma Proteomics to Explore Potential Biomarkers of Diabetic Macular Edema	17
633-P: Insight to the Association between Serum Fibroblast Growth Factor 23 Levels and Presarcopenia in Nondiabetic Individuals—A Longitudinal Cohort Study	17
1764-P: Assessing Gene Expression Profile and Insulin Secretion in Human Beta Cells (EndoC-BH3) under Glucose Exposure	17
366-P: Machine Learning Reveals CGM Superiority over Hypoglycemia Awareness Questionnaires in Discriminating Individuals with Severe Hypoglycemia	16
967-P: The Use of Hybrid Closed-Loop Insulin Delivery in Adolescents and Young Adults with High-Risk Acute Lymphoblastic Leukemia during Induction Chemotherapy	16
121-OR: Safety, Tolerability, and Metabolic Effects of Once-Weekly GL0034 (Utreglutide) in Individuals with Obesity—A Multiple Ascending Dose Study	16
1127-P: Diabetes Risk in Marginalized Urban Settings in Mexico City	16
255-LB: Defining Functional Phenotype in Human Islets across Endocrine Cell Composition, Donor Age, Sex, and Ancestry	16
179-OR: Improved A1C and TIR with Once-Weekly Insulin Icodec vs. Insulin Glargine U100 in Insulin-Naïve T2D—ONWARDS 1	16
99-OR: AgRP Neuron Hyperactivity Drives Hyperglycemia in a Mouse Model of Type 2 Diabetes	16
58-LB: Antidiabetic Effects of Pediococcus acidilactici pA1c on HFD-Induced Mice	16
30-OR: Effects of Vitamin D Supplementation by Race and Weight Status on Serum Vitamin D Measures and Diabetes Risk in the D2d Study	16

500-P: Causal Effect of SGLT2 Inhibition on Diabetes-Related Retinopathy (DR) and Macular Edema (DME)	16
527-P: Needs of mHealth Diabetes Services from Patients with Poorly Controlled Type 2 Diabetes Mellitus: A Qualitative Study	16
102-OR: Association of Elevated Arterial Stiffness with Cardiac Target Organ Damage in Young Adults with Diabetes: The Search for Diabetes in Youth Study	16
1358-P: Diabetes Prediction without Blood Tests—The Role of Retinal Imaging and Artificial Intelligence	16
1478-P: Incidence and Glucose Trends among Patients with Acute Stroke and Stress Hyperglycemia—Insights from a Descriptive Analysis	16
643-P: Exploring Eating Styles of Older Adults with Type 1 Diabetes (T1D)	16
609-P: Virtual Peer Groups (VPG) for Adolescents and Young Adults (AYA) with Type 1 Diabetes (T1D) : Patient-Reported Importance of Specific Features	16
1823-LB: DiaLOG—A Personalized and Interactive Diabetes Education Platform Empowered with Risk Assessment AI Algorithms and ChatGPT	16
649-P: Preliminary Outcomes of a Transition Intervention with Adolescents and Young Adults (AYAs) with Type 1 Diabetes (T1D)	16
1667-P: Mesenteric Visceral Lipectomy (MVL) Improves Glucose Tolerance in Patients with Type 2 Diabetes (T2D)	16
75-LB: CT-388, a Novel Once-Weekly Dual GLP-1 and GIP Receptor Modulator, Is Safe, Well-Tolerated, and Produces More than 8% Weight Loss in Four Weeks in Overweight and Obese Adults	16
1635-P: Sex Differences in Skeletal Muscle Mitochondrial Function in Rats Fed a High-Fat/High-Sucrose Diet	15
1720-P: Epigenetic Regulator Slug Directly Promotes Beige Adipogenesis	15
603-P: Diabetes Distress Is Associated with Poor Glycemic Control after Islet Autotransplantation	15
264-OR: Incorporating Shared Decision-Making to Facilitate Equitable Insulin Pump Use among Pediatric Patients with Type 1 Diabetes	15
105-OR: Single-Cell Multiomic Analysis of the Effect of GIP and GIP-1 Mono- and Multi-agonism on the Hypothalamus and Hindbrain	15
1268-P: P-tau217 and Cognitive Function in Long-Duration Type 1 Diabetes	15
1117-P: Comparison between Glucose Management Indicator (GMI) with HbA1c among Patients in a Hybrid Therapeutics Care Model	15
261-LB: Hepatocyte Gdf15 Protects against CCL4-Induced Liver Injury Independent of Changes in Feeding and Inflammation	15
111-OR: Vascular Endothelium-Specific ROCK2 Deficiency Inhibits the Progression of Obesity via Adipocyte Browning	15
1492-P: IL-8/CXCL8 May Identify a New Type 1 Diabetes Endotype	15
248-OR: Diabetes Remission after Gastric Bypass Is Characterized by Upregulation of LXR and Antioxidant-Related Pathways in Jejunum	15
431-P: Effects of CB1 Antagonist INV-202 in Patients with Metabolic Syndrome—A Randomized, Placebo-Controlled, Double-Blind Phase 1B Study	15
1387-P: Impacts of Androgen-Deprivation Therapy on Glucose Metabolism	14
475-P: Intermittent Hypoxia Increased the Expression of Intercellular Adhesion Molecule-1 and Endothelial Cell–Specific Molecule-1 in Vascular Endothelial Cells via the Downregulation of MicroRNA-181a	14
1616-P: MENTSH—A Mitochondrial Microprotein and SNP-Associated with Diabetes in People with Native American Ancestry	14
1811-PUB: Real-World Safety of the Combined Use of Dapagliflozin and Metformin in Type 2 Diabetes Mellitus Patients in China—Post Hoc Analysis of the DONATE Study	14
1574-P: FoxO1 Links Insulin Resistance to Hepatic Inflammation and Catalyzes the Evolution of Benign Steatosis to Nonalcoholic Steatohepatitis	14
74-PUB: Knowledge, Attitude, and Practice of Individuals with Obesity—Insights from a Large Nationwide Survey	14
546-P: Comparing Diabetes Risk Perception between Latina and White Women with T2D Risk Factors	14
1687-P: Similarities and Differences between Metabolically Unhealthy Lean and Metabolically Unhealthy Obese Individuals	14
1190-P: Oral Health Status among U.S. Adults with and without Diabetes, 2020	14
213-LB: Combined Oral Contraceptives Drive Inactivity and Hepatic Mitochondrial Oxidative Stress in Female Mice	14
160-LB: Age-Related Adipose Tissue Fibrosis and Neuropathy in the Genetically Diverse HET3 Mouse	14
218-OR: Time of Exercise Affects Nocturnal Hypoglycemia after Exercise in Adults with Type 1 Diabetes (T1D)—Results from the T1D Exercise Initiative (T1DEXI) Study	14
1416-P: Differences in Treatment and Metabolic Outcome between Males and Females Living with T2D—Results from the Multicenter DPV Registry	14
1051-P: Cost-Effectiveness of Flash CGM Compared with SMBG—A Canadian Private-Payer Perspective	14
531-P: Continuous Glucose Monitoring Placement during Physical Activity	14
1278-P: Changes in Cardiovascular Disease (CVD) Incidence Due to Remission of Diabetes and Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD)	14
55-LB: Effect of Dapagliflozin on Renal and Hepatic Glucose Kinetics in T2DM and NGT Subjects	14
1117-P: Variability in Glycemia Measured by CGM in Children and Young Adults with Acute Recurrent or Chronic Pancreatitis	14
11-PUB: Transitioning from Dulaglutide to Tirzepatide Improves Glycemic Control in Patients Undergoing Hemodialysis with Type 2 Diabetes—An Assessment by Continuous Glucose Monitoring	14
1463-P: Heterozygous Variant in NFKB1 Presenting with Autoantibody-Negative (AbNeg) Insulin-Dependent Diabetes (IDDM)	14
1410-P: Impacts of COVID-19 on Underserved Communities with Diabetes	13
1797-LB: Detection of Potential Therapeutic Target Associated with Coronary Artery Disease in Type 2 Diabetes Patients—System Biology Approach	13
1767-P: Body Composition and Body Mass Index among People with and without Diabetes—A National Analysis, 2011–2018	13
1044-P: Advancing Quality Improvement Culture among 27 Pediatric and Adult Diabetes Centers	13
658-P: Evaluating Financial Incentives as a Tool to Increase Medication Adherence—A Systematic Review and Meta-analysis	13
1792-LB: Long-Term Impact of Glucose Status on Risk of Restenosis after Percutaneous Transluminal Coronary Angioplasty—A Six-Year Follow-up Study	13
665-P: Association between Housing Insecurity and Hemoglobin A1c among Adults with Type 2 Diabetes—A Cross-Sectional Analysis of the All of Us Research Program	13
201-LB: Benefit of Dual Therapy with GLP-1 RA and SGLT2i on Renal Outcomes in Type 2 Diabetes	13
410-P: Development and Validation of a Risk Score for Predicting the Initiation of Dialysis in People with and without Diabetes Mellitus	13
75-PUB: The Sartorius Fat Fraction Is Independently Associated with Myocardial Fibrosis in Chinese Patients with Obesity	13
1899-LB: The Predictors and Management of Eating Disorders in Adult Patients with Type 1 Diabetes Mellitus	13
18-OR: Discontinuation of Renin Angiotensin System Inhibitor and Cardiovascular-Renal Events in Advanced Diabetic Kidney Disease	13
437-P: Coronary Calcium Score and Cardiovascular Events in Ketosis-Prone Diabetes Compared with T2DM	13
217-LB: Heterogeneity of Single Cells Obtained from Peripheral Blood Mononuclear Cells Collected from Youth with Recent-Onset Type 1 Diabetes	13
1101-P: Patient-Centered Weight Management Clinical Decision Support—A Proof-of-Concept Study	13
389-P: A Six-Month Periodic Fasting Reduces Microalbuminuria and Improves Metabolic Control in Patients with Type 2 Diabetes and Diabetic Nephropathy: A Randomized Controlled Study	13
750-P: Association of Glucagon-Like Peptide 1 Receptor Agonists with Incident Parkinson’s Disease in U.S. Older Adults with Type 2 Diabetes	13
1692-P: Metabolic Assessment of Semaglutide (a GLP-1R Agonist) and Tirzepatide (a GLP-1R/GIPR Coagonist) in Diet-Induced Obese (DIO) Mice	13
1893-LB: Effects of High Fibers and Probiotics Supplements Diet and Lifestyle Intervention in Type 2 Diabetes or Prediabetes—A Randomized, Double-Blind, Placebo-Controlled Pilot Trial	13
721-P: Mechanisms of Relapse after Lifestyle Intervention–Induced Remission of Prediabetes	13
1821-PUB: Relationship between Time in Range and Glucose Management Indicator in Adolescents and Children with Type 1 Diabetes Mellitus	13
280-LB: Efficacy of a Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults with Preexisting Medical Conditions	13
438-P: Very-Low-Dose Metformin Can Safely Improve Glycemic Control in Type 2 Diabetic Patients Receiving Maintenance Hemodialysis (HD)	13
1499-P: Diabetes Technology Use and Acute Complications in Type 1 Diabetes—Racial Disparities Still Persist	13
1998-LB: Previously Frozen Beta-Cell Transcriptional Response to Cytokine Treatment Mirrors That of Fresh Beta Cells	12
1804-LB: Serum Spexin Level Is Negatively Associated with Peripheral Neuropathy and Sensory Pain in Type 2 Diabetes	12
842-P: Improvement in Time in Range after Smart Insulin Pen Initiation in Austria	12
2101-LB: Recruitment Strategies to Increase the Reach of the National Diabetes Prevention Program in Rural Populations	12
Erratum. Foxo1 Inhibits Diabetic Mucosal Wound Healing but Enhances Healing of Normoglycemic Wounds. Diabetes 2015;64:243–256	12
827-P: Patient-Reported Outcomes with Use of Inhaled Technosphere Insulin (TI)	12
783-P: Elucidating the Benefit of Pump-Delivered Subcutaneous GLP-1R Agonist—Exploratory Study in the DIO Mouse	12
1777-P: Three-Dimensional Imaging Reveals Pancreatic Islet Fast Calcium Wave Origin Formation	12
600-P: The Healthy Gut Diet for Preventing Gestational Diabetes Improves Dietary Intake and Diet Quality	12
978-P: Correlation between Continuous Glucose Monitoring Metrics, Oral Glucose Tolerance Test, and HbA1c in Individuals with Impaired Glucose Tolerance	12
1041-P: Assessing the Value of Managing Diabetic Kidney Disease from a U.S. Health Care Perspective	12
391-P: Targeted Deletion of Rho-Associated Coiled-Coil–Containing Protein Kinase 2 in Kidney Tubules Suppresses Expression and Function of Mineralocorticoid Receptor in Mice	12
Issues and Events	12
In This Issue of Diabetes	12
252-OR: Associations of Serum Lipid Profiles with Diabetic Macular Edema and Retinal Structural Alterations	12
946-P: Multicenter Quality Improvement Project: Increasing Depression Screening across Six Pediatric Endocrinology Centers in the U.S.	12
1928-LB: Understanding the Burden of Digital Care—Field Testing the TBQ+D in Patients Living with Diabetes	12
19-OR: Monitoring Stage 2 to Stage 3 Transition in Type 1 Diabetes Using Continuous Glucose Monitoring (CGM)	12
1809-PUB: Painful Diabetic Neuropathy—Patients Treated with High-Frequency (10 kHz) Spinal Cord Stimulation (SCS) Experience Significant Reductions in A1C and Weight	12
495-P: Fully Immersive Virtual Reality Improves Empathy towards People with Diabetes	12
507-P: Trajectories of Inflammatory Proteins over Diabetic Wound Healing Course	12
134-OR: NOD1 Deletion in Skeletal Muscle Protects against Palmitate-Induced Insulin Resistance	12
63-PUB: Diabetes Control and Complications in South India—Three-Year Results of LANDMARC Trial	12
1435-P: Improvements in Metabolic Health from Spanish-Delivered Care Are Similar to English-Delivered Care in a Carbohydrate-Restricted Nutrition Therapy Program	12
422-P: Type 2 Diabetes and the Individual Perception of Risk for Cardiovascular Death in Coronary Artery Disease Patients	12
Erratum. DNA Methylation–Dependent Restriction of Tyrosine Hydroxylase Contributes to Pancreatic β-Cell Heterogeneity. Diabetes 2023;72:575–589	11
Pancreatic β-Cell TRAPδ Deficiency Reduces Insulin Production but Improves Insulin Sensitivity	11
Single-Cell Transcriptome Profiling of Pancreatic Islets From Early Diabetic Mice Identifies Anxa10 for Ca2+ Allostasis Toward β-Cell Failure	11